Peter Sebbel

Peter Sebbel is an experienced professional in the biotech and pharmaceutical industries, currently serving as Head of Biosample Science. With a robust skill set in sequence analysis, biological screening, and bioinformatics, they have a proven track record in pharma development and clinical sample management. Peter has previously held significant roles at Roche and Novartis, where they led global teams and initiatives that earned multiple awards for innovation. They earned a PhD in Natural Sciences from the Eidgenössische Technische Hochschule Zürich and hold certification as a SAFe Agilest.